Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Nephrology (kidneys)

  • 1
    News

    DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use

    September 25, 2020

    Until now, SGLT2 inhibitors were for patients with an eGFR of at least 30 mL/min per m2. New evidence moves the threshold down to 25.

  • News

    Deaths sky high in hospitalized COVID patients with kidney injury

    September 9, 2020

    “We may be facing an epidemic of post–COVID-19 kidney disease and that, in turn, could mean much greater numbers of patients who require kidney dialysis and even transplants.”

  • 1
    News

    DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes

    August 31, 2020

    DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.

  • 1
    News

    Real-world data show SGLT2 inhibitors for diabetes triple DKA risk

    July 29, 2020

    The findings are based on the use of three different SGLT2 inhibitors in Canada and the United Kingdom.

  • 1
    News

    One-year mortality after dialysis initiation nearly double prior estimates

    July 3, 2020

    What is the 1-year mortality rate after dialysis initiation in patients older than age 65 years?

  • 1
    News

    Canagliflozin protects diabetic kidneys

    July 1, 2020

    Do ­sodium-glucose cotransporter 2 (SGLT2) medications protect at-risk kidneys in type 2 diabetics?

  • News

    Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?

    June 22, 2020

    Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that dexamethasone could reduce deaths in the severely ill.

  • News

    Large COVID-19 dataset: Kidney injury in >35% of those in hospital

    May 20, 2020

    The clearest risk factors for the development of AKI were “the need for ventilator support or vasopressor drug treatment.”

  • 1
    News

    Acute kidney injury in children hospitalized with diarrheal illness in the U.S.

    April 29, 2020

    Diarrheal illness is the fourth leading cause of death for children younger than 5 years and the fifth leading cause of years of life lost globally.

  • News

    Dapagliflozin trial in CKD halted because of high efficacy

    March 30, 2020

    An independent data monitoring committee recommended stopping the trial.

Previous1 … 3 4 5 6 7 … 9Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences